Visionary Founders
Invest alongside the original innovators who still lead their companies today. These stocks represent businesses where founding visionaries maintain hands-on leadership, bringing their passion, insight, and long-term commitment to drive exceptional growth.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Tesla, Inc.
TSLA
Current price
$329.31
Led by co-founder Elon Musk, whose ambitious vision dictates the company's pioneering work in electric vehicles, artificial intelligence, and renewabl...
Led by co-founder Elon Musk, whose ambitious vision dictates the company's pioneering work in electric vehicles, artificial intelligence, and renewable energy.
Meta Platforms Inc (Facebook)
META
Current price
$751.48
Founder Mark Zuckerberg continues to command the company's vast social media ecosystem while steering its strategic and resource-intensive pivot into ...
Founder Mark Zuckerberg continues to command the company's vast social media ecosystem while steering its strategic and resource-intensive pivot into the metaverse.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Companies where founders remain at the helm often outperform due to the founder's unmatched passion and long-term vision. These leaders tend to innovate more aggressively and make bold strategic decisions that traditional executives might avoid, potentially unlocking superior growth.
What You Need to Know
This collection targets high-growth potential through companies where the original visionary continues in a key executive role like CEO or Chairman. While this approach embraces higher volatility, it offers exposure to transformative sectors like AI, EVs, enterprise software, and digital platforms.
Why These Stocks
Each company was selected because its founder still actively shapes its strategy and culture. These leaders maintain direct influence in navigating competitive landscapes and are uniquely positioned to capitalize on emerging opportunities like the AI revolution with decisive, agile action.
Group Performance Snapshot
Stocks Rated Buy by Analysts
11 of 14 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Visionaries See Further
Founder-led companies often spot industry shifts before others. These leaders aren't just running businesses; they're pursuing their life's vision with unmatched determination and insight.
AI Revolution Advantage
These agile founder-led companies can pivot faster to capture AI opportunities than traditional corporations with layers of bureaucracy, potentially offering explosive growth as this technology transforms industries.
Skin in the Game
Founders typically maintain significant ownership stakes, aligning their interests with yours as an investor. When they win, you win, creating a powerful incentive for long-term value creation.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Beyond The App Store: Europe's New Rules
Following regulatory pressure from the European Union, Google has revised its Play Store rules to permit alternative payment systems. This change creates a new investment opportunity in companies poised to benefit from a more open mobile app ecosystem.
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Frequently Asked Questions
Everything you need to know about the product and billing.